BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7532849)

  • 1. Localization of cytokines in cholesteatoma tissue.
    Marenda SA; Aufdemorte TB
    Otolaryngol Head Neck Surg; 1995 Mar; 112(3):359-68. PubMed ID: 7532849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of interleukin-1 in middle ear cholesteatoma.
    Shiwa M; Kojima H; Kamide Y; Moriyama H
    Am J Otolaryngol; 1995; 16(5):319-24. PubMed ID: 7503375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aural cholesteatoma: role of tumor necrosis factor-alpha in bone destruction.
    Sastry KV; Sharma SC; Mann SB; Ganguly NK; Panda NK
    Am J Otol; 1999 Mar; 20(2):158-61. PubMed ID: 10100515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and biochemical studies of bone destruction in cholesteatoma.
    Amar MS; Wishahi HF; Zakhary MM
    J Laryngol Otol; 1996 Jun; 110(6):534-9. PubMed ID: 8763371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of epidermal growth factor, tumor necrosis factor-alpha, and interleukin-1alpha in chronic otitis media with or without cholesteatoma.
    Yetiser S; Satar B; Aydin N
    Otol Neurotol; 2002 Sep; 23(5):647-52. PubMed ID: 12218613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of matrix metalloproteinases in keratinocytes by cholesteatoma debris and granulation tissue extracts.
    Schmidt M; Grünsfelder P; Hoppe F
    Eur Arch Otorhinolaryngol; 2000; 257(8):425-9. PubMed ID: 11073191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of interleukin-1 in human cholesteatoma.
    Ahn JM; Huang CC; Abramson M
    Am J Otolaryngol; 1990; 11(2):71-7. PubMed ID: 2188520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of bone resorption in the etiopathogenesis of acquired middle ear cholesteatoma.
    Xie S; Wang X; Ren J; Liu W
    Eur Arch Otorhinolaryngol; 2017 May; 274(5):2071-2078. PubMed ID: 27981350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular control of bone resorption in chronic otitis media with cholesteatoma].
    Kuczkowski J; Kobierska-Gulida G; Izycka-Swieszewska E; Potocka M; Mikaszewski B; Sierszeń W
    Otolaryngol Pol; 2010; 64(4):219-24. PubMed ID: 20873097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Is reuse of autologous ear ossicles in cholesteatoma or chronic suppurative otitis media justified?].
    Peng JC; Hoppe F
    Laryngorhinootologie; 1994 Jul; 73(7):375-80. PubMed ID: 7916783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptors 2, 3 and 4 (TLR-2, TLR-3 and TLR-4) are expressed in the microenvironment of human acquired cholesteatoma.
    Szczepański M; Szyfter W; Jenek R; Wróbel M; Lisewska IM; Zeromski J
    Eur Arch Otorhinolaryngol; 2006 Jul; 263(7):603-7. PubMed ID: 16538507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A study on expression of tumor necrosis factor alpha in middle ear cholesteatoma and its effect on bone destruction].
    Li Z; Li X; Liu G
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2001 Feb; 15(2):66-7. PubMed ID: 12541866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of cytokines and cell cycle regulating substances in proliferation of cholesteatoma epithelium.
    Tanaka Y; Kojima H; Miyazaki H; Koga T; Moriyama H
    Laryngoscope; 1999 Jul; 109(7 Pt 1):1102-7. PubMed ID: 10401849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Epithelium-stroma interaction in cholesteatoma of the middle ear].
    Jacob R; Welkoborsky HJ; Mann W
    Laryngorhinootologie; 2001 Jan; 80(1):11-7. PubMed ID: 11272241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of a cell-cycle-associated nuclear antigen (MIB 1) in cholesteatoma and auditory meatal skin.
    Sudhoff H; Bujía J; Fisseler-Eckhoff A; Holly A; Schulz-Flake C; Hildmann H
    Laryngoscope; 1995 Nov; 105(11):1227-31. PubMed ID: 7475881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of tumor necrosis factor-α, interleukin-1α, interleukin-6 and interleukin-10 in chronic otitis media with bone osteolysis.
    Kuczkowski J; Sakowicz-Burkiewicz M; Iżycka-Świeszewska E; Mikaszewski B; Pawełczyk T
    ORL J Otorhinolaryngol Relat Spec; 2011; 73(2):93-9. PubMed ID: 21311206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the IL-6/JAK/STAT3 signaling pathway in human middle ear cholesteatoma epithelium.
    Liu W; Xie S; Chen X; Rao X; Ren H; Hu B; Yin T; Xiang Y; Ren J
    Int J Clin Exp Pathol; 2014; 7(2):709-15. PubMed ID: 24551293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholesteatoma in children: histopathologic findings in middle ear ossicles.
    Quaranta A; Bartoli R; Lozupone E; Resta L; Iurato S
    ORL J Otorhinolaryngol Relat Spec; 1995; 57(5):296-8. PubMed ID: 8587786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cathepsin L activity and its inhibitor in human otitis media.
    Kusunoki T; Nishida S; Murata K; Kobashi K; Nakatani H; Hiwasa T; Tomura T
    J Otolaryngol; 2001 Jun; 30(3):157-61. PubMed ID: 11771045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of BMP-2, BMP-4 and BMP-6 on bone destruction of cholesteatoma presence.
    Oger M; Alpay HC; Orhan I; Onalan EE; Yanilmaz M; Sapmaz E
    Am J Otolaryngol; 2013; 34(6):652-7. PubMed ID: 23927997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.